Grant Number:	5R01CA141531-04 Interpret this number
Primary Investigator:	Hatsukami, Dorothy
Organization:	University Of Minnesota
Project Title:	Novel Determinants and Measures of Smokeless Tobacco Use
Fiscal Year:	2012

DESCRIPTION (provided by applicant): Currently, there are 7.7 million smokeless tobacco users in the U.S. Smokeless tobacco use has been associated with increased risk of oral pathologies (including oral cancer), pancreatic cancer, diabetes and other components of the metabolic syndrome, fetal toxicity and possibly cardiovascular disease. The extent of these health risks may be associated with the amount of toxicants in these products and the extent of exposure to these toxicants. Research has shown wide variability in carcinogens as well as nicotine in these products. The WHO Framework Convention on Tobacco Control and the proposed FDA legislative bill for tobacco product regulation have provisions that would require tobacco companies to reduce or eliminate harmful toxicants and to reduce levels of nicotine. However, very little research is available to guide decision makers on the impact of reducing toxicants and nicotine nor do we completely understand factors other than product toxicity that are associated with the extent of toxicant exposure. Two studies are proposed with the following goals: 1) Study 1 will examine brands of U.S. smokeless tobacco (ST) products that contain different levels of tobacco specific nitrosamines (TSNAs), other carcinogens and nicotine on existing and novel biomarkers of exposure and effect. In addition, this study will comprehensively determine factors that moderate the extent of exposure other than the levels of toxicants in these products. These factors include individual, social and environmental influences. Subjects will be recruited from 3 different regions in the U.S. and will be assessed on two different occasions. This study will contribute new information on critical factors associated with toxicant exposure. 2) Study 2 will determine the effects of switching ST users to lower TSNA and high, moderate or low nicotine ST products on pattern of use, biomarkers of exposure and toxicity, and facilitation of abstinence. Subjects will undergo measurements during use of their usual brand of smokeless tobacco and then switch to the assigned product for 12 weeks, with follow-up at week 13 and 26. This study would demonstrate the feasibility and impact of switching ST users to less toxic ST products. Together, these studies will help to guide important policy decisions to reduce the toll of tobacco-related disease.




3-Ethenylpyridine Measured in Urine of Active and Passive Smokers: A Promising Biomarker and Toxicological Implications.
Authors: Liu J. , Benowitz N.L. , Hatsukami D.K. , Havel C.M. , Lazcano-Ponce E. , Strasser A.A. , Jacob P. .
Source: Chemical Research In Toxicology, 2021-06-21 00:00:00.0; 34(6), p. 1630-1639.
EPub date: 2021-05-17 00:00:00.0.
PMID: 33998799
Related Citations

Assessing Constituent Levels in Smokeless Tobacco Products: A New Approach to Engaging and Educating the Public.
Authors: Borgida E. , Loken B. , Williams A.L. , Vitriol J. , Stepanov I. , Hatsukami D. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2015 Nov; 17(11), p. 1354-61.
PMID: 25634934
Related Citations

Evidence supporting product standards for carcinogens in smokeless tobacco products.
Authors: Hatsukami D.K. , Stepanov I. , Severson H. , Jensen J.A. , Lindgren B.R. , Horn K. , Khariwala S.S. , Martin J. , Carmella S.G. , Murphy S.E. , et al. .
Source: Cancer Prevention Research (philadelphia, Pa.), 2015 Jan; 8(1), p. 20-6.
PMID: 25524878
Related Citations

Public education about the relative harm of tobacco products: an intervention for tobacco control professionals.
Authors: Biener L. , Nyman A.L. , Stepanov I. , Hatsukami D. .
Source: Tobacco Control, 2014 Sep; 23(5), p. 385-8.
PMID: 23481906
Related Citations

Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
Authors: Stepanov I. , Biener L. , Yershova K. , Nyman A.L. , Bliss R. , Parascandola M. , Hatsukami D.K. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2014 Aug; 16(8), p. 1070-8.
PMID: 24604020
Related Citations

Flavored and nonflavored smokeless tobacco products: rate, pattern of use, and effects.
Authors: Oliver A.J. , Jensen J.A. , Vogel R.I. , Anderson A.J. , Hatsukami D.K. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2013 Jan; 15(1), p. 88-92.
PMID: 22529222
Related Citations

Increased pouch sizes and resulting changes in the amounts of nicotine and tobacco-specific N-nitrosamines in single pouches of Camel Snus and Marlboro Snus.
Authors: Stepanov I. , Jensen J. , Biener L. , Bliss R.L. , Hecht S.S. , Hatsukami D.K. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2012 Oct; 14(10), p. 1241-5.
PMID: 22259150
Related Citations

Monitoring tobacco-specific N-nitrosamines and nicotine in novel Marlboro and Camel smokeless tobacco products: findings from Round 1 of the New Product Watch.
Authors: Stepanov I. , Biener L. , Knezevich A. , Nyman A.L. , Bliss R. , Jensen J. , Hecht S.S. , Hatsukami D.K. .
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2012 Mar; 14(3), p. 274-81.
PMID: 22039075
Related Citations

Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products.
Authors: Hecht S.S. , Stepanov I. , Hatsukami D.K. .
Source: Tobacco Control, 2011 Nov; 20(6), p. 443.
PMID: 20930058
Related Citations